Interní Med. 2004; 6(4): 194-199

Praktické aspekty léčby fibrilace síní: nefarmakologické postupy

doc. MUDr. Josef Kautzner, CSc., FESC, MUDr. Petr Peichl

Keywords: atrial fibrillation, cardiac pacing, cardioversion, surgical ablation, catheter ablation.

Published: December 31, 2004  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kautzner J, Peichl P. Praktické aspekty léčby fibrilace síní: nefarmakologické postupy. Interní Med. 2004;6(4):194-199.

doc. MUDr. Josef Kautzner, CSc., FESC, MUDr. Petr Peichl

Klinika kardiologie, Institut klinické a experimentální medicíny, Praha

V posledních letech dochází k značnému rozvoji nefarmakologické léčby fibrilace síní. Kromě paliativní metody sloužící ke kontrole komorové odpovědi při arytmii, kterou je katetrizační ablace nebo modifikace AV vedení, přicházejí nové možnosti síňové stimulace, defibrilace, kurativní chirurgické a katetrizační ablace. Nejperspektivnější se jeví katetrizační ablace.

Practical aspects of atrial fibrilation treatment: non-pharmacological methods

Recent years have witnessed significant development of non-pharmacological treatment of atrial fibrillation. Besides catheter ablation or modification of AV conduction that represents paliative method for ventricular rate control, novel therapeutic options are increasingly used such as atrial pacing, defibrillation, surgical and/or catheter ablation. The most promissing appears to be catheter ablation.

Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Lévy S, Breithardt G, Campbell RWF, et al. Atrial fibrillation: current knowledge and recommendations for management. Eur Heart J 1998; 19: 1294-1320. Go to original source... Go to PubMed...
    2. Hohnloser SH, Kuck KH, Lilenthal J, for the PIAF Investigators: Rhythm or rate control in atrial fibrillation: Pharmacological intervention in atrial fibrillation (PIAF): a randomized trial. Lancet 2000; 356: 1789-1794. Go to original source... Go to PubMed...
    3. The Atrial Fibrillation Follow-up Invetigation of Rhythm Management (AFFIRM) Investigators: A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002; 347: 1825-1833. Go to original source... Go to PubMed...
    4. Van Gelder I, Hagens VE, Bosker HA, et al, for the Rate Control versus Electrical Cardioversion for Persistent atrial fibrillation (RACE) Study Group. A comparison of rate control and rhythm control in patients with recurrent atrial fibrillation. N Engl J Med 2002; 347: 1834-1840. Go to original source... Go to PubMed...
    5. Pappone C, Rosanio S, Augello G, et al. Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study. J Am Coll Cardiol. 2003; 42: 185-97. Go to original source... Go to PubMed...
    6. Cooper JM, Katcher MS, Orlov MV. Implantable devices for the treatment of atrial fibrillation. N Engl J Med 2002; 346: 2062-2068. Go to original source... Go to PubMed...
    7. Rosenqvist M, Brandt J, Schuller H. Long-term pacing in sinus node disease: the effects of stimulation mode on cardiovascular morbidity and mortality. Am Heart J 1988; 116: 16-22. Go to original source... Go to PubMed...
    8. Hesselson AB, Parsonet V, Bernstein AD, et al. Deleterious effects of long-term single-chamber ventricular pacing in patients with sick sinus syndrome: the hidden benefits of dual-chamber pacing. J Am Coll Cardiol 1992; 19: 1542-1549. Go to original source... Go to PubMed...
    9. Andersen HR, Theusen L, Bagger J, et al. Prospective randomized trial of atrial versus ventricular pacing in sick sinus syndrome. Lancet 1994; 344: 1923-1928. Go to original source... Go to PubMed...
    10. Schoels W, Swerdlow DC, Jung W, et al. Worldwide clinical experience with a new dual chamber implantable cardioverter defibrillator system. J Cardiovasc Electrophysiol 2001; 12: 521-528. Go to original source... Go to PubMed...
    11. Coumel P, Friocourt P, Mugica J, et al. Long-term prevention of vagal atrial arrhythmias by atrial pacing at 90/minute: experience with 6 cases. PACE 1983; 6: 552-560. Go to original source... Go to PubMed...
    12. Katsivas A, Manolis AG, Lazaris E, et al. Atrial septal pacing to resynchronize atrial depolarization in patients with delayed interatrial conduction. PACE 1998; 21: 2220-2225. Go to original source... Go to PubMed...
    13. Papageorgiu P, Anselme P, Kirchhof CJ, et al. Coronary sinus pacing prevents induction of atrial fibrillation. Circulation 1997; 96: 1893-1898. Go to original source... Go to PubMed...
    14. Prakash A, Delfaut P, Krol RB, Saksena S. Regional right and left atrial activation patterns during single- and dual-site atrial pacing in patients with atrial fibrillation. Am J Cardiol 1998; 82: 1197-1204. Go to original source... Go to PubMed...
    15. Saksena S, Prakash A, Ziegler P, et al. Improved suppression of recurrent atrial fibrillation with dual-site right atrial pacing and antiarrhythmic drug therapy. J Am Coll Cardiol 2002; 40: 1140-1150. Go to original source... Go to PubMed...
    16. Garrigue S, Barold SS, Cazeau S, et al. Prevention of atrial arrhythmias during DDD pacing by atrial overdrive. PACE 1998; 21: 1751-1759. Go to original source... Go to PubMed...
    17. Funck RC, Adamec R, Lurje L, et al. Atrial overdriving is beneficial in patients with atrial arrhythmias: first results of the PROVE study. PACE 2000; 23: 1891-1893. Go to original source... Go to PubMed...
    18. Schmitt C, Alt E, Plevan A, et al. Low-energy intracardiac cardioversion after failed conventional external cardioversion of atrial fibrillation. J Am Coll Cardiol 1996; 28: 994-999. Go to original source... Go to PubMed...
    19. Daoud EG, Timmermans C, Fellows C, et al. Intial clinical experience with ambulatory use of an implantable atrial defibrillator for conversion of atrial fibrillation. Circulation 2000; 102: 1407-1413. Go to original source... Go to PubMed...
    20. Moe GK. On the multiple wavelet hypothesis of atrial fibrillation. Arch Int Pharmacodyn Ther 1962; 140: 183-188.
    21. Cox JL, Schuessler RB, D´Agostino HJ Jr, et al. The surgical treatment of atrial fibrillation. III. Development of a definite surgical procedure. J Thorac Cardiovasc Surg 1991; 101: 569-583. Go to original source...
    22. Cox JL. The surgical treatment of atrial fibrillation. IV. Surgical technique. J Thorac Cardiovasc Surg 1991; 101: 584-592. Go to original source...
    23. Cox JL, Schuessler RB, Lappas DG, Boineau JP. An 8 1/2 -year clinical experience with surgery for atrial fibrillation. Ann Surg 1996; 224: 267-275. Go to original source... Go to PubMed...
    24. Kosakai Y, Kawaguchi AT, Isobe F, et al. Cox maze procedure for chronic atrial fibrillation associated with mitral valve disease. J Thorac Cardiovasc Surg 1994; 108: 1049-1055. Go to original source...
    25. Izumoto H, Kawazoe K, Kitahara H, Kamata J. Operative results after the Cox/ Maze procedure combined with a mitral valve operation. Ann Thorac Surg 1998; 66: 800-804. Go to original source... Go to PubMed...
    26. Arcidi JM, Millar RC. Evolution of the maze III procedure: are modifications necessary? Thorac Cardiovasc Surg 1999; 47: 362-364. Go to original source... Go to PubMed...
    27. Tuinenburg AE, van Gelder IC, Tieleman RG, et al. Mini-maze suffices as adjunct to mitral valve surgery in patients with preoperative atrial fibrillation. J Cardiovasc Electrophysiol 2000; 11: 960-967. Go to original source... Go to PubMed...
    28. Sueda T, Nagata H, Orihashi K, et al. Efficacy of a simple left atrial procedure for chronic atrial fibrillation in mitral valve disease. Ann Thorac Surg 1997; 63: 1070-1075. Go to original source... Go to PubMed...
    29. Melo JQ, Neves J, Adragao P, et al. When and how to report results of surgery on atrial fibrillation. Eur J Cardio-thorac Surg 1997; 12: 739-745. Go to original source... Go to PubMed...
    30. Kottkamp H, Mohr FW, Autschbach R, et al. Intraoperative cure from atrial fibrillation using radiofrequency energy: development of a safe and effective treatment strategy using minimally invasive techniques. PACE 1999; 22 (suppl): 848.
    31. Kautzner J, Pirk J, Bytešník J, Mičkal R. První zkušenosti s chirurgickou lineární ablací chronické fibrilace síní pomocí radiofrekvenční energie. Cor Vasa 2001; 43 (Suppl): 37.
    32. Haissaguerre M, Gencel L, Fischer B, et al. Successful catheter ablation of atrial fibrillation. J Cardiovasc Electrophzsiol 1994; 5: 1045-1052. Go to original source... Go to PubMed...
    33. Swartz JF, Pellersels G, Silvers J, et al. A catheter-based curative approach to AF in humans (abstr). Circulation 1994; 90 (part I): 335.
    34. Haissaguerre M, Jais P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998; 339: 659-666. Go to original source... Go to PubMed...
    35. Haissaguerre M, Shah DC, Jais P, et al. Electrophysiological breakthroughs from the left atrium to the pulmonary veins. Circulation 2000; 102: 2463-2465. Go to original source... Go to PubMed...
    36. Pappone C, Rosanio S, Oreto G, et al. Circumferential radiofrequency ablation of pulmonary vein ostia: a new anatomic approach for curing atrial fibrillation. Circulation 2000; 102: 2619-2628. Go to original source... Go to PubMed...
    37. Cappato R, Negroni S, Pecora D, et al. Prospective assessment of late conduction recurrence across radiofrequency lesions producing electrical disconnection at the pulmonary vein ostium in patients with atrial fibrillation. Circulation 2003; 108: 1599-1604. Go to original source... Go to PubMed...
    38. Oral H, Scharf C, Chugh A, et al. Catheter ablation for paroxysmal atrial fibrillation: segmental pulmonary vein ostial ablation versus left atrial ablation. Circulation 2003; 108: 2355-2360. Go to original source... Go to PubMed...
    39. Marrouche NF, Martin DO, Wazni O, et al. Phased-array intracardiac echocardiography monitoring during pulmonary vein isolation in patients with atrial fibrillation: impact on outcome and complications. Circulation 2003; 107: 2710-2716. Go to original source... Go to PubMed...
    40. Kay N, Bubien R, Epstein A, et al. Effect of catheter ablation of the atrioventricular junction on quality of life and exercise tolerance in paroxysmal atrial fibrillation. Am J Cardiol 1988; 62: 741-744. Go to original source... Go to PubMed...
    41. Rodriguez LM, Smeets J, Xie B, et al. Improvement in left ventricular function by ablation of atrioventricular nodal conduction in selected patients with lone atrial fibrillation. Am J Cardiol 1993; 72: 1137-1141. Go to original source... Go to PubMed...
    42. Brignole M, Gianfranchi L, Menozzi C, et al. Assessment of atrioventricular junction ablation and DDDR mode switching pacemaker versus pharmacological treatment in patients with severely symptomatic paroxysmal atrial fibrillation. A randomized controlled study. Circulation 1997; 96: 2617-2624. Go to original source... Go to PubMed...
    43. Williamson B, Ching Man K, Daoud E, et al. Radiofrequency catheter modification of atrioventricular conduction to control ventricular rate during atrial fibrillation. N Engl J Med 1994; 331: 910-917. Go to original source... Go to PubMed...
    44. Della Bella P, Carbucicchio C, Tondo C, et al. Modulation of atrioventricular conduction by ablation of the, ,slow" atrioventricular node pathway in patients with drug refractory atrial fibrillation or flutter. J Am Coll Cardiol 1995; 25: 39-46. Go to original source... Go to PubMed...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.